补肾强骨方治疗多发性骨髓瘤的临床效果

杨阳

（陕西省汉中市人民医院整形外科，陕西 汉中，723099）

浏览次数：110次 下载次数：367次

摘要：

目的 探讨对多发性骨髓瘤患者给予补肾强骨方治疗的临床效果。方法 选取我院收治的多发性骨髓瘤患者76 例为研 究对象，将其分为试验组和对照组，每组38 例。对照组患者给予VAD 联合沙利度胺治疗，试验组患者给予VAD 联合补肾强 骨方治疗。比较两组患者的临床效果。结果 两组患者总有效率比较，差异无统计学意义（P>0.05）；治疗后，两组患者的M 蛋 白、HgB、浆细胞比例、β2-MG 及CRP 水平明显优于治疗前（P<0.05），但两组患者组间比较，差异无统计学意义（P>0.05）。结论 对多发性骨髓瘤患者给予补肾强骨方治疗，能够抑制血管新生，使患者的病情得到改善。

关键词：多发性骨髓瘤；补肾强骨方；沙利度胺

中图分类号：R733.3 文献标志码：A文章编号：2096-1413(2018)02-0120-02

Clinical effect of Bushen Qianggu decoction in the treatment of multiple myeloma


YANG Yang
(Plastic Surgery Department, the People``s Hospital of Hanzhong, Hanzhong 723099, China)

ABSTRACT: Objective To investigate the clinical effect of Bushen Qi anggu decoction in the treatment of multiple myeloma. Methods Seventy-six patients with multiple myeloma admitted in our hospital were selected and divided into experimental group and control group, with 38 cases in each group. The control group was given VAD combined with thaiidomide, and the experimental group was treated with VAD combined with Bushen Qianggu decoction. The clinical effects of the two groups were compared. Results There was no significant difference in the total effective rate between the two groups (P>0.05). After treatment, the levels of M protein, HgB, plasma cell rate,β2-MG and CRP in the two groups were better than those before treatment (P<0.05), but there were no significant differences in those between the two groups (P>0.05). Conclusion Bushen Qianggu decoction in the treatment of multiple myeloma can inhibit angiogenesis and improve the patients`` condition.
KEYWORDS: multiple myeloma; Bushen Qianggu decoction; thaiidomide

参考文献：
[1] 黄智莉,于天启,陈亚勇,等.补肾强骨方治疗多发性骨髓瘤临床观察[J].北京中医药大学学报,2016,34(6):520-523.
[2] 陈雪鹏,胡晓峰,宋增武.玻璃酸钠联合补肾强骨方治疗膝关节骨性关节炎临床观察[J].实用中医药杂志,2015,31(9):838.
[3] 胡晓峰,陈雪鹏,宋增伍.玻璃酸钠联合补肾强骨方对膝骨性关节炎患者血清炎性因子水平的影响[J].医学理论与实践,2015,28(17):2290-2291.
[4] 彭建,李万逸,李海平,等.补肾健骨方治疗骨质疏松性椎体骨折的临床疗效分析[J].中国实用医药,2013,8(17):42-44.